xmlns:atom="http://www.w3.org/2005/Atom" xmlns:atom="http://www.w3.org/2005/Atom"

SCHEDULE 2U.K.AMENDMENTS TO RETAINED DIRECT EU LEGISLATION

227.—(1) Article 15 is amended as follows.U.K.

(2) For “Annex I to that Regulation” substitute “ the Simplified Active Substance List ”.

(3) In point (a)—

(a)for “the person placing the product on the market” insert “ the product was placed on the market before [F1IP completion day] and the person placing the product on the market ”;

(b)after the words “by the Commission” insert “ before [F1IP completion day] or the competent authority after [F1IP completion day].

(4) After point (a) insert—

(aa)the product was placed on the market after [F2IP completion day] and the person placing the product on the market has relied on guidance published by, or written advice received from, the competent authority after [F2IP completion day], where that guidance or advice gave objectively justified reasons to believe that the product was excluded from the scope of Regulation (EU) No 528/2012, or that the relevant product-type was one for which the active substance had been notified and where that guidance or advice is subsequently reviewed in a decision issued pursuant to Article 3(3) of Regulation (EU) No 528/2012 [F3or in new, authoritative guidance published by the Competent Authority];.

(5) In point (b), at the end insert “ and the person placing the product on the market has complied with the time limits provided for by Regulation (EU) No 528/2012 ”.

(6) Omit point (c).